Anti-TNF-α and hydralazine drug-induced lupus

AbstractDrug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-T...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Victória Quaresma (Author), Fred Bernardes Filho (Author), Fernanda Brandão de Oliveira (Author), Mercedes Prates Pockstaller (Author), Maria Fernanda Reis Gavazzoni Dias (Author), David Rubem Azulay (Author)
Format: Book
Published: Sociedade Brasileira de Dermatologia, 2015-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AbstractDrug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment.
Item Description:0365-0596
10.1590/abd1806-4841.20153893